Cargando…
Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
Epstein–Barr virus- (EBV-) induced posttransplantation lymphoproliferative disease (PTLD) is a life-threatening complication following allogeneic stem cell transplantation. The main risk factor is anti-thymocyte globulin (ATG). Patients who fail first-line treatment with rituximab have a poor progno...
Autores principales: | Weum Abrahamsen, Ingerid, Grønvold, Bjørn Christer, Inderberg, Else Marit, Mensali, Nadia, Mattsson, Jonas, Gedde-Dahl, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060862/ https://www.ncbi.nlm.nih.gov/pubmed/32158568 http://dx.doi.org/10.1155/2020/9403123 |
Ejemplares similares
-
Emerging Biomarkers for Immunotherapy in Glioblastoma
por: Mensali, Nadia, et al.
Publicado: (2022) -
A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder
por: Morris, Jaime, et al.
Publicado: (2017) -
Posttransplantation lymphoproliferative disorder involving liver after renal transplantation
por: Shin, Yong Moon
Publicado: (2011) -
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019) -
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019)